These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1859503)
1. Calcium antagonists in the treatment of experimental cerebral ischemia. Ginsberg MD; Lin B; Morikawa E; Dietrich WD; Busto R; Globus MY Arzneimittelforschung; 1991 Mar; 41(3A):334-7. PubMed ID: 1859503 [TBL] [Abstract][Full Text] [Related]
2. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile. Hofmann HP; Raschack M; Unger L Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655 [TBL] [Abstract][Full Text] [Related]
3. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death. Szabo L; Hofmann HP Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657 [TBL] [Abstract][Full Text] [Related]
4. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects. Szabo L Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656 [TBL] [Abstract][Full Text] [Related]
5. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats. Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449 [TBL] [Abstract][Full Text] [Related]
6. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats. Gemba T; Ninomiya M; Matsunaga K; Ueda M J Pharmacol Exp Ther; 1993 Apr; 265(1):463-7. PubMed ID: 8474028 [TBL] [Abstract][Full Text] [Related]
7. (S)-emopamil protects against global ischemic brain injury in rats. Lin BW; Dietrich WD; Busto R; Ginsberg MD Stroke; 1990 Dec; 21(12):1734-9. PubMed ID: 2264081 [TBL] [Abstract][Full Text] [Related]
8. (S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Nakayama H; Ginsberg MD; Dietrich WD Neurology; 1988 Nov; 38(11):1667-73. PubMed ID: 3185899 [TBL] [Abstract][Full Text] [Related]
9. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate. Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Yang Y; Li Q; Shuaib A Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442 [TBL] [Abstract][Full Text] [Related]
12. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage. Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Møller A; Christophersen P; Drejer J; Axelsson O; Peters D; Jensen LH; Nielsen EO Neurol Res; 1995 Oct; 17(5):353-60. PubMed ID: 8584126 [TBL] [Abstract][Full Text] [Related]
14. Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Zhu H; Meloni BP; Bojarski C; Knuckey MW; Knuckey NW Exp Neurol; 2005 Jun; 193(2):361-8. PubMed ID: 15869938 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion. Fan Y; Shi L; Gu Y; Zhao Y; Xie J; Qiao J; Yang GY; Wang Y; Lu CZ J Cereb Blood Flow Metab; 2007 Apr; 27(4):719-28. PubMed ID: 16868556 [TBL] [Abstract][Full Text] [Related]
16. Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia. Wang J; Lei B; Popp S; Meng F; Cottrell JE; Kass IS Neuroscience; 2007 Mar; 145(3):1097-107. PubMed ID: 17291693 [TBL] [Abstract][Full Text] [Related]
17. Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain. Bielenberg GW; Haubruck H; Krieglstein J J Cereb Blood Flow Metab; 1987 Aug; 7(4):489-96. PubMed ID: 3611207 [TBL] [Abstract][Full Text] [Related]
18. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]